GE HealthCare Technologies (NASDAQ:GEHC) Releases FY 2025 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.610-4.750 for the period, compared to the consensus estimate of 4.650. The company issued revenue guidance of -.

GE HealthCare Technologies Stock Down 2.0 %

Shares of GEHC traded down $1.91 during trading hours on Friday, reaching $91.57. The company’s stock had a trading volume of 884,656 shares, compared to its average volume of 2,756,302. The company has a 50 day moving average of $83.81 and a two-hundred day moving average of $85.44. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $41.84 billion, a price-to-earnings ratio of 25.18, a P/E/G ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. As a group, research analysts predict that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.15%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $97.31.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.